Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Speaking Valve vs Capping Trial for Tracheostomy Decannulation in Stroke Patients

Official title: Comparison of Speaking Valve Trial and Capping Trial in the Decannulation Process for Stroke Patients: A Randomized, Controlled, Multicenter Study

Run by Capital Medical University · NCT07435727 · Data updated 2026-11-12

We’re testing whether using a Passy-Muir Speaking Valve helps decide when to remove a tracheostomy tube in stroke patients, compared with traditional tracheostomy tube capping.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment120 (estimated)
SponsorCapital Medical University
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 15, 2026
Main results expectedMay 15, 2027
Study endsAugust 15, 2027
Registry record updatedMay 22, 2026
Trial IDNCT07435727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Stroke patients with tracheostomies who are clinically stable, off ventilators for at least 48 hours, and meet the specified physiological criteria.

Probably not a fit

Patients with unstable condition, ongoing infections requiring IV antibiotics, or significant airway abnormalities may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, randomized study compares two methods used before decannulation in stroke survivors: the Passy-Muir Speaking Valve and the traditional cuff deflation/capping approach. It is outcomes-assessor-blinded with an exploratory crossover element to gather robust safety and efficacy data across diverse centers. Eligible participants are post-acute stroke patients with tracheostomies who are clinically stable and off ventilators for at least 48 hours. The trial aims to determine which method better supports timely and safe decannulation while minimizing complications. Results could inform standardized decannulation protocols in stroke rehabilitation settings.

Why it matters

Potential benefit: If successful, the trial could identify a preferred method that enables faster, safer decannulation and improved communication for stroke patients.

How similar studies have gone: Previous approaches have shown mixed results; this study adds rigorous comparative data for decannulation strategies in stroke.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Stroke (ischemic or hemorrhagic) with subsequent tracheostomy. Stable stage of stroke: clinically in the post-acute or sequelae stage, with stable vital signs, resolved cerebral edema, normalized intracranial pressure, no new neurological deficits.

Clinically stable, defined as: ventilator-free for ≥48 hours prior to enrollment; stable vital signs (temperature \<38°C, heart rate 60-100 bpm, respiratory rate \<20/min, systolic blood pressure 90-160 mmHg); no active severe infection requiring IV antibiotics; no organ failure; partial pressure of Carbon Dioxide(PaCO₂) \<60 mmHg.

Peak Cough Flow (PCF) ≥100 L/min. 24-hour subglottic secretion volume \<20 ml. Signed informed consent by patient or legal representative.

Exclusion Criteria:

Intolerance to cuff deflation: severe cough, dyspnea, SpO₂ \<93% (on supplemental oxygen), or respiratory rate \>20/min for \>5 minutes.

Severe airway structural abnormalities: tracheal stenosis (\>50% lumen occlusion confirmed by Computed Tomography or bronchoscopy), tracheoesophageal fistula.

Life expectancy \<2 weeks or planned transfer to a non-participating institution within 2 weeks.

Severe uncontrolled neurological or systemic diseases (e.g., advanced cancer, severe heart failure).

Where it's running

  • Beijing Rehabilitation Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.